human
bocaviru
hbov
parvoviru
first
identifi
use
protocol
base
dnase
treatment
random
pcr
amplif
highthroughput
sequenc
bioinformat
analysi
virusscreen
techniqu
initi
appli
nasopharyng
swab
wash
children
unresolv
respiratori
tract
infect
gave
posit
result
rate
henc
propos
hbov
caus
pathogen
respiratori
tract
diseas
three
addit
hbov
subtyp
subsequ
identifi
human
stool
sampl
name
differenti
first
isol
subtyp
name
notabl
studi
respiratori
faecal
sampl
shown
presenc
hbov
associ
potenti
pathogen
led
hypothesi
viru
may
harmless
passeng
rather
true
pathogen
moreov
viru
detect
biolog
sampl
includ
blood
saliva
faec
urin
well
environment
sampl
includ
river
water
sewag
convers
recent
research
rais
concern
presenc
transfus
medicin
hbov
found
individu
age
although
mainli
affect
infant
age
mo
respiratori
symptom
base
upon
koch
modifi
postul
howev
viru
yet
confirm
caus
agent
diseas
due
lack
anim
model
andor
difficulti
replic
vitro
cultur
cell
thu
research
discuss
potenti
role
pathogen
alon
combin
type
virus
patient
respiratori
infect
gastroenter
go
review
examin
current
knowledg
recent
find
taxonomi
biolog
epidemiolog
pathogenesi
diagnosi
method
hbov
hbov
genotyp
belong
famili
parvovirida
subfamili
parvovirina
genu
bocaviru
caus
infect
vertebr
exclus
famili
parvovirida
also
compris
subfamili
densovirina
infect
arthropod
share
sequenc
homolog
subfamili
current
classif
intern
committe
taxonomi
virus
databas
recogn
eight
genera
subfamili
parvovirina
amdoparvoviru
aveparvoviru
bocaparvoviru
copiparvoviru
dependoparvoviru
erythroparvoviru
protoparvoviru
tetraparvoviru
name
bocaviru
deriv
combin
term
bovin
parvoviru
bpv
canin
minut
viru
cmv
base
sequenc
similar
genom
organ
two
close
rel
parvovirus
associ
human
infect
parvoviru
within
genu
erythroparvoviru
apathogen
adenoassoci
viru
belong
genu
dependoparvoviru
recent
discov
parvovirus
affili
new
genu
tetraparvoviru
latter
yet
associ
clinic
signific
base
similar
howev
alloc
new
genu
hokoviru
among
human
parvovirus
particularli
relev
sinc
acknowledg
etiolog
agent
erythema
infectiosum
also
known
fifth
diseas
character
caus
agent
condit
children
eg
transient
arthriti
adult
eg
nonimmun
hydrop
fetali
sever
autoimmun
diseas
spontan
abort
arthropathi
despit
close
phylogenet
relationship
hbov
appear
strongli
diverg
natur
exampl
show
tropism
bone
marrow
lifelong
persist
heart
tissu
hbov
persist
lymphat
tissu
tissu
afflict
chronic
sinus
parvovirus
small
icosahedr
nonenvelop
virus
nm
diamet
contain
singl
molecul
linear
neg
positivesens
singlestrand
dna
length
linear
singlestrand
hbov
genom
kilobas
plu
termin
sequenc
nucleotid
nt
play
key
role
viru
replic
show
high
similar
termin
sequenc
bpv
cmv
replic
mechan
hbov
remain
elus
two
conflict
model
propos
roll
hairpin
versu
rollingcycl
replic
parvoviru
occur
via
rollinghairpin
model
gener
concatenamer
intermedi
character
headtohead
tailtotail
structur
howev
presenc
headtohead
monom
demonstr
concatenamer
intermedi
found
yet
convers
recent
data
support
hypothesi
hbov
natur
infect
becom
persist
establish
host
cell
form
extrachromosom
close
circular
episom
instead
concatem
date
episom
structur
found
hbov
genotyp
addit
headtotail
sequenc
detect
sampl
patient
respiratori
infect
kapoor
et
al
identifi
headtotail
monom
episom
circular
form
genom
intestin
biopsi
child
gastrointestin
diseas
complet
genom
shown
contain
nt
flank
ntlong
termin
noncod
sequenc
meanwhil
circular
genom
nt
nt
repres
noncod
termin
region
detect
well
recent
studi
demonstr
replic
form
genotyp
compris
headtotail
nucleotid
sequenc
circular
form
futur
research
effort
delv
deeper
hbov
replic
mechan
like
improv
comprehens
pathogenet
role
hbov
substanti
genom
hbov
organ
three
open
read
frame
orf
encod
two
form
nonstructur
ns
protein
encod
addit
ns
protein
nuclear
phosphoprotein
encod
two
structur
viral
capsid
protein
gener
result
altern
splice
event
noncod
region
contain
palindrom
sequenc
commonli
known
invert
termin
repeat
essenti
viral
replic
multifunct
protein
variou
site
differ
function
nterminu
bind
endonucleas
cterminu
transactiv
middl
region
atpas
helicas
furthermor
role
dna
replic
similar
function
essenti
dna
replic
cmv
minut
viru
mice
nonstructur
protein
also
particip
apoptosi
cellcycl
arrest
gene
transactiv
recent
novel
small
ns
protein
identifi
studi
base
upon
transfect
infecti
provir
plasmid
viral
infect
polar
human
airway
epithelium
cell
cultur
airliquid
interfac
haeali
protein
contain
predict
domain
activ
moreov
function
import
viral
dna
replic
human
embryon
kidney
cell
line
play
critic
role
replic
haeali
cultur
well
also
small
nonstructur
protein
function
still
need
fulli
elucid
initi
shown
induc
cell
cycl
arrest
apoptosi
transfect
hela
cell
recent
studi
howev
shown
play
critic
role
express
viral
capsid
protein
demonstr
direct
involv
viral
dna
replic
replic
origin
orir
share
ctermin
region
differ
ntermin
region
exert
phospholipas
activ
essenti
infect
facilit
releas
viru
endocyt
compart
nucleu
host
cell
date
mechan
underli
viral
cell
entri
vivo
hostrang
remain
unclear
complet
gene
sequenc
nt
long
encod
polypeptid
amino
acid
aa
residu
much
shorter
cmv
bpv
gene
nt
long
encod
protein
vari
length
among
differ
strain
rang
aa
residu
moreov
orf
contain
complet
code
sequenc
gene
nt
encod
protein
aa
residu
gene
within
sequenc
encod
nucleotid
genom
organ
differ
hbov
genotyp
obtain
use
illustr
biolog
sequenc
softwar
packag
shown
figur
phylogenet
tree
refseq
nucleotid
aa
code
region
hbov
genom
construct
neighborjoin
method
implement
program
shown
figur
remark
sequenc
cluster
homolog
sequenc
strain
hold
true
convers
sequenc
similar
provid
evid
may
result
recombin
virus
figur
low
level
polymorph
warrant
predomin
role
recombin
genom
prone
rapid
evolut
context
recombin
mutat
repres
major
mechan
genet
variat
parvoviru
evolut
thu
surpris
propos
recent
human
bocavirus
group
rearrang
two
cluster
speci
human
bocaparvoviru
includ
previou
human
bocaparvoviru
includ
previou
alreadi
state
pathogenesi
hbov
remain
poorli
character
mainli
due
lack
specif
cell
line
viru
cultur
experiment
anim
model
first
studi
present
vitro
cultur
system
hbov
date
back
wherein
pseudostratifi
haeali
deriv
primari
human
bronchial
epitheli
cell
util
tool
hbov
replic
attempt
made
previous
cell
line
vero
etc
unsuccess
like
due
lack
express
certain
receptor
make
cell
suscept
respiratori
virus
haeali
model
previous
use
infect
wide
rang
respiratori
rna
virus
influenza
virus
human
coronavirus
among
other
apic
surfac
unlik
respiratori
dna
virus
accomplish
basolater
surfac
virion
capabl
product
persist
infect
hae
apic
basolater
surfac
consequ
infect
induct
airway
epitheli
damag
evidenc
loss
cilia
disrupt
tight
junction
barrier
epitheli
cell
hypertrophi
subsequ
commerci
avail
hae
cultur
system
name
epiairway
mattek
ashland
unit
state
mucilair
hae
epithelix
geneva
switzerland
test
infect
despit
result
obtain
hae
made
inhous
innov
find
infect
demonstr
persist
long
recent
data
display
first
time
infect
haeali
induc
dna
damag
respons
facilit
viral
genom
amplif
parallel
cell
line
infect
hbov
exampl
establish
transfect
infecti
clone
cell
gener
high
titr
progeni
virion
viru
enter
host
via
respiratori
tract
bloodstream
direct
ingest
reach
gastrointestin
tract
detect
respiratori
gastrointestin
tract
sever
studi
shown
associ
upper
lower
respiratori
tract
regard
frequent
describ
clinic
present
infect
includ
cough
fever
rhinorrhea
asthma
exacerb
bronchiol
acut
wheez
pneumonia
dna
also
found
stool
sampl
adult
patient
gastrointestin
manifest
nausea
vomit
diarrhoea
howev
stool
sampl
paediatr
patient
acut
gastroenter
report
lower
viral
load
respiratori
tract
sampl
fact
viral
load
median
genomeml
report
stool
sampl
lower
found
nasopharyng
aspir
npa
patient
respiratori
infect
copiesml
well
genotyp
found
often
stool
sampl
possibl
associ
gastroenter
among
speci
isol
npa
children
hospit
acut
respiratori
tract
infect
recent
data
show
hbov
detect
directli
specif
tissu
duodenum
paranas
sinu
mucosa
intestin
biopsi
hbov
monoinfect
rare
doubleinfect
observ
frequent
case
hbov
infect
show
high
rate
coinfect
viral
bacteri
respiratori
gastroenter
pathogen
human
rhinoviru
adenoviru
noroviru
rotaviru
notabl
coinfect
pathogen
found
respiratori
sampl
particular
coinfect
respiratori
syncyti
viru
rsv
occur
frequent
remain
detect
npa
sampl
immunecompet
subject
mo
infect
consequ
often
detect
virus
asymptomat
patient
facilit
reactiv
latent
viru
superinfect
despit
low
tropism
viru
demonstr
human
bodi
hbov
show
high
persist
site
particular
lymphat
tissu
persist
reactiv
hbov
may
explain
high
preval
coinfect
although
effect
mechan
still
unclear
contribut
activ
diseas
remain
accur
establish
addit
individu
low
viral
load
like
coinfect
pathogen
compar
high
viral
load
vs
clinic
relev
infect
requir
hospit
subject
associ
coinfect
six
differ
pathogen
singl
patient
furthermor
high
viral
load
copiesml
shown
multipl
studi
statist
associ
sever
clinic
manifest
longer
hospit
contrast
find
howev
ghietto
et
al
screen
respiratori
sampl
children
adult
symptomat
asymptomat
found
associ
high
viral
load
ill
yet
demonstr
asymptomat
subject
low
viral
load
p
high
viral
load
copiesml
npa
report
christensen
et
al
studi
also
demonstr
viremia
frequent
subject
high
viral
load
moder
low
viru
load
henc
basi
data
report
literatur
date
role
viru
harmless
passeng
rather
true
infect
agent
still
debat
therefor
remain
establish
host
thelper
th
cell
essenti
antivir
immun
sinc
particip
antivir
respons
directli
indirectli
direct
activ
exert
via
product
antivir
cytokin
wherea
indirect
activ
mediat
via
th
pattern
promot
b
cell
cytotox
cell
studi
npa
children
acut
bronchiol
chung
et
al
demonstr
higher
concentr
interferongamma
interleukin
il
hbovposit
subject
compar
asymptomat
control
howev
cytokin
level
tumour
necrosi
factoralpha
lower
found
rsvposit
children
furthermor
studi
demonstr
induc
hbov
vlp
cell
cell
find
suggest
hbov
infect
induc
product
cytokin
date
howev
precis
mechan
underli
hbovspecif
cell
immun
defin
hbov
worldwid
distribut
transmiss
infect
occur
throughout
year
predomin
winter
spring
month
worldwid
distribut
hbov
involv
infect
respiratori
tract
gastrointestin
tract
evidenc
stool
sampl
children
well
adult
europ
asia
america
africa
australia
estim
global
preval
infect
base
upon
search
articl
publish
medlin
databas
septemb
year
hbov
discoveri
march
includ
studi
evalu
respiratori
gastrointestin
hbov
infect
tabl
respect
countri
calcul
preval
estim
confid
interv
ci
per
cent
coinfect
base
pool
data
elig
studi
extract
data
customis
databas
total
use
report
preval
hbov
correl
respiratori
ill
gastrointestin
infect
appendix
averag
preval
hbov
respiratori
tract
sampl
rang
ci
ci
tabl
stool
specimen
ci
ci
depend
countri
tabl
furthermor
worldwid
hbov
total
preval
estim
respiratori
infect
ci
gastrointestin
infect
ci
tabl
respect
respiratori
tract
infect
preval
averag
report
cambodia
ci
kenya
ci
kuwait
ci
seneg
ci
philippin
ci
contrast
highest
preval
averag
report
egypt
ci
hungari
ci
nicaragua
ci
tabl
base
data
avail
gastrointestin
infect
countri
mexico
russia
mostli
low
endem
level
ci
ci
respect
convers
high
hbov
preval
report
bangladesh
ci
nigeria
ci
tunisia
ci
tabl
rate
coinfect
subject
respiratori
infect
hbovposit
rang
ci
tabl
meanwhil
coinfect
ratio
ci
rel
gastrointestin
manifest
tabl
seropreval
hbov
agerel
rang
children
mo
age
virtual
children
older
year
averag
children
adult
serolog
survey
perform
itali
involv
particip
carri
aim
determin
presenc
antihbov
igg
antibodi
studi
show
higher
seroposit
rate
children
year
age
respect
year
age
furthermor
high
seropreval
observ
infant
age
mo
children
first
month
life
assum
relat
matern
antibodi
kantola
et
al
show
hbov
infect
human
frequent
descend
order
recent
seropreval
studi
conduct
beij
nanj
involv
sampl
show
preval
respect
result
consist
previou
serolog
research
conduct
japan
jamaica
find
indic
high
degre
antigen
crossreact
convers
discrep
observ
seropreval
vs
like
due
differ
method
use
fact
enzymelink
immunosorb
assay
elisa
indic
exposur
rate
accumul
infect
pcr
result
reveal
ongo
infect
mani
year
diagnost
tool
avail
identif
etiolog
agent
associ
respiratori
gastroenter
diseas
limit
first
main
method
detect
hbov
infect
respiratori
gastrointestin
sampl
repres
direct
tool
name
convent
pcr
follow
nest
realtim
rt
pcr
pcr
techniqu
enabl
isol
viral
genom
fragment
npa
bronchoalveolar
stool
serum
urin
specimen
amplif
orand
gene
region
via
nucleic
acidbas
detect
hbov
diagnosi
method
conserv
thu
commonli
target
pcrbase
detect
viru
rtpcr
advantag
convent
pcr
specif
rapid
requir
highercost
oligoprob
limit
applic
rtpcr
gene
detect
hbov
swab
faecal
whole
blood
sampl
allow
tozer
et
al
achiev
clinic
sensit
clinic
specif
respect
assay
subsequ
multiplex
assay
develop
detect
hbov
genotyp
respiratori
infect
includ
commerci
avail
luminex
rvp
luminex
molecular
diagnost
toronto
canada
respifind
pathofind
maastricht
netherland
recent
sequenceindepend
amplif
techniqu
combin
nextgener
sequenc
platform
introduc
promis
rapid
simultan
detect
numer
pathogen
despit
current
drawback
ie
high
cost
labour
intens
long
turnaround
time
specif
train
personnel
etc
oppos
rtpcr
new
approach
provid
inform
regard
viru
speciestyp
henc
interest
viru
diagnosi
clinic
public
health
set
serolog
method
develop
estim
hbovspecif
antibodi
serum
sampl
western
blot
immunofluoresc
among
elisa
enzym
immunoassay
eia
reliabl
qualit
quantit
serolog
assay
use
detect
igg
igm
antibodi
igg
affin
use
recombin
vlp
capsid
protein
latter
exampl
produc
insect
cell
line
infect
baculoviru
vector
subsequ
use
produc
rabbit
antihbov
antisera
appli
develop
elisa
test
igg
avid
test
allow
distinguish
primari
secondari
infect
immuneactiv
high
diagnost
specif
recent
data
indic
children
preexist
immun
show
crossreact
present
paradigm
hypothes
origin
antigen
sin
phenomenon
avail
serolog
studi
date
mainli
address
epidemiolog
issu
howev
consid
human
bocavirus
highli
preval
agent
establish
persist
infect
interpret
serolog
test
context
clinic
situat
may
complic
use
pcr
result
notabl
zaghloul
determin
presenc
hbov
children
via
qualit
pcr
detect
npa
elisa
estim
igm
antibodi
serum
assay
highli
sensit
specif
howev
elisa
lower
sensit
pcr
vs
higher
specif
vs
base
current
data
pathogen
role
variou
hbov
genotyp
respiratori
tract
ill
gastrointestin
infect
remain
unresolv
possibl
viru
may
passeng
caus
pathogen
acut
respiratori
tract
gastrointestin
diseas
conflict
idea
pathogen
role
mainli
come
fact
koch
revis
postul
appli
hbov
neither
effect
method
viru
cultur
anim
model
infect
avail
practic
date
moreov
sever
studi
indic
hbov
requir
presenc
agent
carri
infect
recent
studi
demonstr
infect
haeali
induc
dna
damag
respons
facilit
viral
genom
amplif
nonetheless
research
develop
cell
line
anim
model
suitabl
viral
replic
need
order
obtain
evid
better
understand
natur
cours
hbov
infect
respect
simpler
cultur
method
infecti
clone
made
avail
sinc
hbov
genom
analysi
difficult
reason
spite
rel
substanti
amount
knowledg
molecular
basi
hbov
life
cycl
function
sever
hbov
protein
still
requir
investig
instanc
recent
three
novel
small
ns
protein
identifi
among
one
ns
protein
critic
replic
viru
polar
human
bronchial
airway
epithelium
role
protein
remain
rather
uncertain
studi
date
perform
genotyp
wherea
littl
inform
avail
agent
notabl
presenc
respiratori
tract
investig
well
phylogenet
relationship
phylogenet
analysi
suggest
shown
author
may
result
recombin
may
also
hybrid
common
ancestor
respect
would
appropri
futur
studi
test
simultan
possibl
genotyp
gene
hbov
subtyp
found
worldwid
without
region
geograph
border
restrict
associ
paediatr
respiratori
ill
also
gastrointestin
symptom
frequent
detect
stool
sampl
seem
enter
moreov
typic
age
hbov
infect
rare
found
adult
elderli
respect
clinic
studi
would
use
character
diseas
pathogenesi
understand
immun
variou
popul
repres
infant
elderli
immunocompromis
individu
respond
hbov
infect
also
need
optim
commerci
diagnost
reagent
method
hbov
identif
overal
hbov
detect
mainli
perform
via
molecular
techniqu
ie
pcr
rtpcr
rare
done
serolog
method
ie
elisa
eia
western
blot
immunofluoresc
due
lack
commerci
kit
furthermor
develop
new
sequenceindepend
amplif
techniqu
combin
next
gener
sequenc
platform
worthi
achiev
rapid
simultan
detect
numer
pathogen
final
pathogen
role
hbov
confirm
develop
effect
vaccin
control
spread
infect
primari
import
hope
achiev
goal
mani
studi
perform
hbov
viral
capsid
protein
previou
research
studi
confirm
vlp
use
safe
effect
vaccin
recent
vitro
studi
demonstr
hbov
vlp
good
immunogen
studi
mice
shown
induc
strong
humor
cellular
immun
respons
indic
promis
candid
protein
hbov
vaccin
newer
data
suggest
creation
nonrepl
infecti
mutant
may
repres
new
approach
hbov
vaccin
develop
conclus
better
understand
natur
cours
hbov
infect
implement
experiment
system
analys
replic
cycl
detail
develop
specif
therapi
import
urgent
need
